HealthQuill COPD
AstraZeneca’s lung cancer drug, Tagrisso, reduced the risk of death by 51% in the early stages of the disease, according to a company statement.
Drugs Health

AstraZeneca’s asthma drug fails end-stage trial in COPD

HQ Team September 17, 2025: AstraZeneca’s asthma drug Fasenra (benralizumab) has  failed to meet its primary goal in a Phase III trial for.

Read More
The Food and Drug Administration has come out with new product-specific guidances for developing generic drugs and generating evidence to support abbreviated new drug application approvals.
Drugs Health Pharma

FDA draws up new product guidance for developing generic drugs

HQ Team May 21, 2025: The Food and Drug Administration has come out with new product-specific guidances for developing generic drugs and generating.

Read More
The European Medicines Agency has approved Sanofi S.A.’s Dupixent (dupilumab) therapy as an add-on maintenance treatment for adults with uncontrolled chronic obstructive pulmonary disease, according to a company statement.
Drugs Health Pharma

EMA approves Sanofi’s treatment for obstructive pulmonary disease

The European Medicines Agency has approved Sanofi S.A.’s Dupixent (dupilumab) therapy as an add-on maintenance treatment for adults with uncontrolled chronic obstructive pulmonary.

Read More
Drugs Health Medical Pharma

Lab-made lung models facilitate faster drug testing and substitute animal subjects

Scientists in Australia have developed accurate lab models of human lungs that will help in therapeutic testings and do away with the need.

Read More
About 263 million children and young people worldwide are out of school, and achieving education for all by 2030 is "seriously off track," the UN stated. 
Climate Health Pharma

Pandemic, poverty keeping 260 million children out of school: UN

HQ Team April 12, 2023: About 263 million children and young people worldwide are out of school, and achieving education for all by.

Read More